AU3665893A - Sequences characteristic of human gene transcription product - Google Patents

Sequences characteristic of human gene transcription product

Info

Publication number
AU3665893A
AU3665893A AU36658/93A AU3665893A AU3665893A AU 3665893 A AU3665893 A AU 3665893A AU 36658/93 A AU36658/93 A AU 36658/93A AU 3665893 A AU3665893 A AU 3665893A AU 3665893 A AU3665893 A AU 3665893A
Authority
AU
Australia
Prior art keywords
human gene
gene transcription
transcription product
sequences characteristic
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36658/93A
Inventor
Mark D Adams
Ruben F Moreno
Craig J Venter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Government
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Government, US Department of Army filed Critical US Government
Publication of AU3665893A publication Critical patent/AU3665893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU36658/93A 1992-02-12 1993-02-12 Sequences characteristic of human gene transcription product Abandoned AU3665893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83719592A 1992-02-12 1992-02-12
US837195 1992-02-12

Publications (1)

Publication Number Publication Date
AU3665893A true AU3665893A (en) 1993-09-03

Family

ID=25273788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36658/93A Abandoned AU3665893A (en) 1992-02-12 1993-02-12 Sequences characteristic of human gene transcription product

Country Status (2)

Country Link
AU (1) AU3665893A (en)
WO (1) WO1993016178A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014772A1 (en) * 1993-11-12 1995-06-01 Kenichi Matsubara Gene signature
AU1322795A (en) 1993-12-24 1995-07-17 Erasmus University Rotterdam Tuberous sclerosis 2 gene and uses thereof
US5605797A (en) * 1994-09-15 1997-02-25 Board Of Trustees Operating Michigan State University Bovine β-mannosidase gene and methods of use
US5863744A (en) * 1994-10-03 1999-01-26 New England Deaconess Hospital Corporation Neural cell protein marker RR/B and DNA encoding same
US5985598A (en) 1994-10-27 1999-11-16 Thomas Jefferson University TCL-1 gene and protein and related methods and compositions
US7175995B1 (en) 1994-10-27 2007-02-13 Thomas Jefferson University TCL-1 protein and related methods
US5985554A (en) * 1994-11-02 1999-11-16 Takeda Chemical Industries, Ltd. Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
AU3092995A (en) * 1995-06-30 1997-02-05 Human Genome Sciences, Inc. Breast specific genes and proteins
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
AU4105396A (en) 1995-11-02 1997-05-29 Human Genome Sciences, Inc. Mammary transforming protein
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US6509170B1 (en) 1996-03-14 2003-01-21 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor delta
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6468766B1 (en) * 1996-03-15 2002-10-22 President And Fellows Of Harvard College Aortic carboxypeptidase-like polypeptide
EP0960120A4 (en) * 1996-05-06 2001-05-02 Chiron Corp MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
AU2936497A (en) * 1996-05-08 1997-11-26 Chiron Corporation Mammalian additional sex combs (mammalian asx) acts as a tumor suppressor
DE69732711T2 (en) 1996-07-12 2006-03-16 Genentech, Inc., South San Francisco GAMMA-heregulin
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US5917028A (en) * 1996-10-29 1999-06-29 Incyte Pharmaceuticals, Inc. Human phosphoprotein
US5840559A (en) * 1996-10-30 1998-11-24 Incyte Pharmaceuticals, Inc. Human spermidine/spermine N1-acetyltransferase
US5889170A (en) * 1997-01-31 1999-03-30 Incyte Pharmaceuticals, Inc. Human integral membrane protein
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
US5955312A (en) * 1997-02-24 1999-09-21 Incyte Pharmaceuticals, Inc. DNA encoding a novel microtubule-associated protein
CA2281015A1 (en) * 1997-02-26 1998-09-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6171787B1 (en) 1997-06-26 2001-01-09 Abbott Laboratories Member of the TNF family useful for treatment and diagnosis of disease
US5948619A (en) * 1997-07-31 1999-09-07 Incyte Pharmaceuticals, Inc. Human zygin-1
AU8648198A (en) * 1997-08-13 1999-03-08 Chugai Research Institute For Molecular Medicine, Inc. Protein having zn finger-like motif
US6130068A (en) 1998-10-26 2000-10-10 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
US6562949B1 (en) 1997-10-28 2003-05-13 Immunex Corporation Antibodies to viral encoded semaphorin protein receptor polypeptides
EP1027436A1 (en) * 1997-10-28 2000-08-16 Immunex Corporation Viral encoded semaphorin protein receptor dna and polypeptides
US7214497B2 (en) 1997-10-28 2007-05-08 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
US6277565B1 (en) * 1997-11-06 2001-08-21 Millennium Pharmaceuticals, Inc. OCT-3 gene encoding transporter-like molecules
US5916753A (en) * 1997-11-13 1999-06-29 Incyte Pharmaceuticals, Inc. SH3-containing proteins
WO2000006708A1 (en) 1998-07-29 2000-02-10 Kyowa Hakko Kogyo Co., Ltd. Novel polypeptide
EP1119624A2 (en) 1998-10-09 2001-08-01 Genset Nucleic acids encoding human cide-b protein and polymorphic markers thereof
US6355788B1 (en) 1998-10-15 2002-03-12 Zymogenetics, Inc. Follistatin-related protein zfsta2
EP1123393A1 (en) * 1998-10-15 2001-08-16 ZymoGenetics, Inc. Follistatin-related protein zfsta2
EP1141288A2 (en) * 1998-12-18 2001-10-10 Incyte Pharmaceuticals, Inc. Lymphocytic membrane proteins
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
GB9900167D0 (en) * 1999-01-06 1999-02-24 Univ Leeds Wound an tissue healing and orofacial clefting
DE19908423A1 (en) * 1999-02-26 2000-08-31 Deutsches Krebsforsch Protein involved in the development of the CNS
JP2002537832A (en) * 1999-03-09 2002-11-12 シエーリング アクチエンゲゼルシャフト Human nucleic acid and protein sequences from endothelial cells
US6558910B2 (en) 1999-09-10 2003-05-06 The Regents Of The University Of California SF, a novel family of taste receptors
WO2001018050A2 (en) 1999-09-10 2001-03-15 The Regents Of The University Of California T2r taste receptor family
CN1382156A (en) 1999-10-22 2002-11-27 惠氏 PABLO polypeptide that interacts with BCL-XL and uses related thereto
US7164001B2 (en) * 2000-01-20 2007-01-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2394022A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001081361A1 (en) * 2000-04-11 2001-11-01 Cogent Neuroscience, Inc. Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death
EP1209229A1 (en) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gene involved in schizophrenia
WO2002052005A1 (en) 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Novel genes and proteins encoded thereby
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
WO2002094192A2 (en) 2001-05-24 2002-11-28 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (april)
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
PE20130207A1 (en) 2010-05-06 2013-02-28 Novartis Ag ANTIBODIES ANTAGONISTS TO LRP6 (LOW DENSITY LIPOPROTEIN-RELATED PROTEIN 6) AND COMPOSITIONS
SG185415A1 (en) 2010-05-06 2012-12-28 Novartis Ag Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
AU2012332263A1 (en) 2011-11-04 2014-05-22 Novartis Ag Low density lipoprotein-related protein 6 (LRP6) - half life extender constructs

Also Published As

Publication number Publication date
WO1993016178A3 (en) 1993-11-25
WO1993016178A2 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
AU3665893A (en) Sequences characteristic of human gene transcription product
AU2240492A (en) Sequences characteristic of human gene transcription product
AU4106193A (en) Inflatable sheath for introduction of ultrasonic catheter
AU4277093A (en) Clad metallurgical products and methods of manufacture
AU6042396A (en) Amplification of nucleic acid sequences
AU6614696A (en) Inhibition of gene expression
AU4331497A (en) Oligomers which inhibit expression of interleukin genes
AU5669494A (en) Human homolog of the e-cadherin gene and methods based thereon
AU1173195A (en) Treatment of immunoregulatory disorders
AU6614596A (en) Inhibition of gene expression
AU8153794A (en) Methods of inhibiting autoimmune diseases
AU6092394A (en) Amplification of nucleic acid sequences
AU6819194A (en) Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
AU2861892A (en) Astrocyte-specific transcription of human genes
EP0731647A4 (en) Treatment of an edible product with humectants
AU6010294A (en) Modulators of gene expression
AU3362293A (en) Control of gene transcription
AU6040296A (en) Methods of inducing bef-1 transcription factor
AU7671394A (en) Expression control sequences of the p-selectin gene
AU5845294A (en) Novel process and intermediates for the preparation of prodrugs
AU4641393A (en) Use of mtr gene sequences for expression of foreign genes
AU2548095A (en) Human inhibitor of apoptosis gene 1
AU672019B2 (en) Method of integrating gene into chromosome of (lactobacillus delbrueckii) species and product of gene integration
AU4489196A (en) Novel medical use of heme products
AU8007094A (en) High pressure treatment of food